Mallinckrodt Hospital Products Inc. recalls Acthar Gel (repository corticotropin injection)
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- Presence of particulate matter: glass and stopper piece
- Products
-
- Acthar Gel (repository corticotropin injection)
- Where it was sold
-
USA Nationwide
Nationwide
- Units affected
- 12367 vials
- About this recall
- Acthar Gel (repository corticotropin injection), 5 mL multiple-dose vial, Rx Only, Mfd. for: Mallinckrodt ARD LLC, Bridgewater, NJ 08807, NDC 63004-8710-1 & NDC 63004-8710-2